Literature DB >> 33477385

Progress in the Enantioseparation of β-Blockers by Chromatographic Methods.

Yiwen Yang1,2, Yehui Wang1, Zongbi Bao1,2, Qiwei Yang1,2, Zhiguo Zhang1,2, Qilong Ren1,2.   

Abstract

β-adrenergic antagonists (β-blockers) with at least one chiral center are an exceedingly important class of drugs used mostly to treat cardiovascular diseases. At least 70 β-blockers have been investigated in history. However, only a few β-blockers, e.g., timolol, are clinically marketed as an optically pure enantiomer. Therefore, the separation of racemates of β-blockers is essential both in the laboratory and industry. Many approaches have been explored to obtain the single enantiomeric β-blocker, including high performance liquid chromatography, supercritical fluid chromatography and simulated moving bed chromatography. In this article, a review is presented on different chromatographic methods applied for the enantioseparation of β-blockers, covering high performance liquid chromatography (HPLC), supercritical fluid chromatography (SFC) and simulated moving bed chromatography (SMB).

Entities:  

Keywords:  HPLC; SFC; SMB; chromatography; enantioseparation; β-blockers

Mesh:

Substances:

Year:  2021        PMID: 33477385      PMCID: PMC7830546          DOI: 10.3390/molecules26020468

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  90 in total

Review 1.  Chiral separation by chromatographic and electromigration techniques. A review.

Authors:  G Gübitz; M G Schmid
Journal:  Biopharm Drug Dispos       Date:  2001 Oct-Nov       Impact factor: 1.627

2.  Studies on the effect of alcohols on the chiral discrimination mechanisms of amylose stationary phase on the enantioseparation of nebivolol by HPLC.

Authors:  H Y Aboul-Enein; I Ali
Journal:  J Biochem Biophys Methods       Date:  2001-04-24

3.  Chiral separation of beta-blockers after derivatization with a new chiral derivatization agent, GATC.

Authors:  Mi Young Ko; Dae Hong Shin; Joung Weon Oh; Workaferhaw Shibru Asegahegn; Kyeong Ho Kim
Journal:  Arch Pharm Res       Date:  2006-11       Impact factor: 4.946

Review 4.  Beta-blockers: Historical Perspective and Mechanisms of Action.

Authors:  Eduardo Oliver; Federico Mayor; Pilar D'Ocon
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2019-06-06

Review 5.  HPLC separation of amino acid enantiomers and small peptides on macrocyclic antibiotic-based chiral stationary phases: a review.

Authors:  István Ilisz; Róbert Berkecz; Antal Péter
Journal:  J Sep Sci       Date:  2006-07       Impact factor: 3.645

Review 6.  Enantioselective bioanalysis of beta-blocking agents: focus on atenolol, betaxolol, carvedilol, metoprolol, pindolol, propranolol and sotalol.

Authors:  G Egginger; W Lindner; C Vandenbosch; D L Massart
Journal:  Biomed Chromatogr       Date:  1993 Nov-Dec       Impact factor: 1.902

7.  Separation of enantiomers on chiral stationary phase based on cellulase: Effect of preparation method and silica particle diameters on chiral recognition ability.

Authors:  Hisami Matsunaga; Jun Haginaka
Journal:  J Chromatogr A       Date:  2016-05-21       Impact factor: 4.759

8.  Reversed-phase high-performance liquid chromatographic enantioresolution of six beta-blockers using dinitrophenyl-L-Pro-N-hydroxysuccinimide ester, N-succinimidyl-(S)-2-(6-methoxynaphth-2-yl) propionate and twelve variants of Sanger's reagent as chiral derivatizing reagents.

Authors:  Ravi Bhushan; Shivani Tanwar
Journal:  Biomed Chromatogr       Date:  2009-12       Impact factor: 1.902

9.  Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary process.

Authors:  J A Nathanson
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

10.  A multi-residue method by supercritical fluid chromatography coupled with tandem mass spectrometry method for the analysis of chiral and non-chiral chemicals of emerging concern in environmental samples.

Authors:  Jack Rice; Anneke Lubben; Barbara Kasprzyk-Hordern
Journal:  Anal Bioanal Chem       Date:  2020-07-09       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.